Soberana02

Cuba produced 10 million doses of Soberana 02 and Soberana Plus

Published on: August 26, 2021
16:26

Havana, Aug 26 (Prensa Latina) Cuba's Molecular Immunology Center (CIM) announced on Thursday they managed to produce 10 million doses of their own vaccines against Covid-19, Soberana 02 and Soberana Plus.

Cuba advances on vaccination trial in children under 12

Published on: June 28, 2021
08:57

Havana, Jun 28 (Prensa Latina) The first group of children between 3 and 11 years old included in Cuba's Covid-19 clinical trial called 'Soberana Pediatría' (lit. 'Soberana Pedriatics') is receiving their first dose of Soberana 02 today.

Cuban president highlights success of Covid-19 vaccine candidates

Published on: June 22, 2021
14:33

Havana, Jun 22 (Prensa Latina) Cuban President Miguel Diaz-Canel on Tuesday highlighted the effectiveness of vaccine candidates Soberana 02 and Abdala, developed in this nation against Covid-19.

Cuba, Argentina termed fruitful exchange on anti-Covid-19 candidates

Published on: May 29, 2021
08:46

Havana, May 29 (Prensa Latina) The BioCubaFarma Business Group described the meeting held Friday with Argentina´s Health Minister Carla Vizzoti, visiting Cuba to learn about progress of anti-Covid-19 vaccine candidates, as fruitful.

More than one million Cubans vaccinated against Covid-19

Published on: May 21, 2021
15:10

Havana, May 21 (Prensa Latina) Five Cuban vaccine candidates, developed by several scientific institutions, and more than one million doses administered in different clinical trials characterize Cuba's current Covid-19 vaccination strategy.

Cuba’s Soberana 02 to complement its 3rd phase in Iran

Published on: April 20, 2021
00:30

Tehran, Apr 20 (Prensa Latina) Cuba's vaccine candidate against Covid-19, Soberana 02, will soon begin the complementary studies of the 3rd phase clinical trials in Iran, according to the Pasteur Institute of that country.

NEWS